MX337145B - Composiciones farmaceuticas. - Google Patents

Composiciones farmaceuticas.

Info

Publication number
MX337145B
MX337145B MX2012004282A MX2012004282A MX337145B MX 337145 B MX337145 B MX 337145B MX 2012004282 A MX2012004282 A MX 2012004282A MX 2012004282 A MX2012004282 A MX 2012004282A MX 337145 B MX337145 B MX 337145B
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
administration
risk
treating
preventing
Prior art date
Application number
MX2012004282A
Other languages
English (en)
Other versions
MX2012004282A (es
Inventor
Danping Li
Eric S Burak
Original Assignee
Melinta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Therapeutics Inc filed Critical Melinta Therapeutics Inc
Publication of MX2012004282A publication Critical patent/MX2012004282A/es
Publication of MX337145B publication Critical patent/MX337145B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se relaciona con composiciones farmacéuticas útiles para la administración para tratar, prevenir o reducir el riesgo de infecciones microbianas.
MX2012004282A 2009-10-13 2010-10-12 Composiciones farmaceuticas. MX337145B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25102309P 2009-10-13 2009-10-13
PCT/US2010/052263 WO2011046905A2 (en) 2009-10-13 2010-10-12 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
MX2012004282A MX2012004282A (es) 2012-05-22
MX337145B true MX337145B (es) 2016-02-15

Family

ID=43876821

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012004282A MX337145B (es) 2009-10-13 2010-10-12 Composiciones farmaceuticas.

Country Status (16)

Country Link
US (2) US20120208857A1 (es)
EP (2) EP2488175A4 (es)
JP (3) JP2013507443A (es)
KR (1) KR101791709B1 (es)
CN (1) CN102573840A (es)
AU (2) AU2010307054A1 (es)
BR (1) BR112012008649A2 (es)
CA (1) CA2776310A1 (es)
EA (1) EA022765B1 (es)
IL (1) IL219018A (es)
MX (1) MX337145B (es)
NZ (1) NZ599151A (es)
PH (1) PH12012500695A1 (es)
SG (1) SG10201406571YA (es)
UA (1) UA111145C2 (es)
WO (1) WO2011046905A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2642996B1 (en) 2010-11-24 2020-09-23 Melinta Subsidiary Corp. Pharmaceutical compositions
CN104784113B (zh) * 2015-04-30 2017-09-29 成都国为生物医药有限公司 一种含有利奈唑胺的组合物及其制备方法
US11112370B2 (en) * 2019-01-04 2021-09-07 The Boeing Company Reconfigurable backscatter detector

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
PE20011088A1 (es) * 2000-03-22 2001-10-04 Upjohn Co Tratamiento de infecciones del tracto urinario con oxazolidinonas antibacterianas
MY127336A (en) * 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
MXPA02012045A (es) 2000-06-05 2003-10-15 Dong A Pharm Co Ltd Nuevos derivados de oxazolidinona y proceso para su preparacion.
PE20020300A1 (es) * 2000-08-22 2002-05-10 Pharmacia Corp Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
CN1713924A (zh) * 2000-08-22 2005-12-28 法马西亚公司 药物含量增加的噁唑烷酮抗菌药物溶液组合物
US6696426B2 (en) * 2000-08-22 2004-02-24 Pharmacia Corporation Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems
MXPA05013132A (es) 2003-06-03 2006-05-25 Rib X Pharmaceuticals Inc Compuestos heterociclicos de biarilo y metodos de produccion y su uso.
WO2005070904A2 (en) * 2003-06-03 2005-08-04 Rib-X Pharmaceutical, Inc. Sulfonamide compounds and methods of making and using the same
JP2007514782A (ja) 2003-12-17 2007-06-07 リブ−エックス ファーマシューティカルズ，インコーポレイテッド ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US7696211B2 (en) * 2005-04-29 2010-04-13 Wilson Constance N Methods and pharmaceutical compositions for treating sepsis
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
WO2007086011A1 (en) * 2006-01-25 2007-08-02 Jegannathan Srinivas Formulation comprising cefepime, tazobactam and linezolid
WO2007133803A2 (en) * 2006-05-15 2007-11-22 Rib-X Pharmaceuticals, Inc. Treatment of mycobacterial infections
US20080139563A1 (en) * 2006-10-23 2008-06-12 Concert Pharmaceuticals Inc. Oxazolidinone derivatives and methods of use
WO2008085913A1 (en) 2007-01-04 2008-07-17 Rib-X Pharmaceuticals, Inc. Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections

Also Published As

Publication number Publication date
EA201270547A1 (ru) 2012-12-28
UA111145C2 (uk) 2016-04-11
IL219018A0 (en) 2012-06-28
IL219018A (en) 2016-11-30
CA2776310A1 (en) 2011-04-21
AU2016234893A1 (en) 2016-10-20
EA022765B1 (ru) 2016-02-29
US20150165040A1 (en) 2015-06-18
KR101791709B1 (ko) 2017-10-30
WO2011046905A3 (en) 2011-10-20
EP2488175A4 (en) 2013-08-07
JP2017141285A (ja) 2017-08-17
MX2012004282A (es) 2012-05-22
JP2015155479A (ja) 2015-08-27
BR112012008649A2 (pt) 2021-11-03
EP2488175A2 (en) 2012-08-22
US20120208857A1 (en) 2012-08-16
NZ599151A (en) 2014-07-25
KR20120099676A (ko) 2012-09-11
WO2011046905A2 (en) 2011-04-21
JP2013507443A (ja) 2013-03-04
EP3095445A1 (en) 2016-11-23
AU2010307054A1 (en) 2012-04-26
PH12012500695A1 (en) 2024-02-12
SG10201406571YA (en) 2014-11-27
CN102573840A (zh) 2012-07-11

Similar Documents

Publication Publication Date Title
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
IL253038A0 (en) Preparations and methods for the treatment or prevention of infections. my voice
MX2015007556A (es) Derivados de manosa para tratar infecciones bacterianas.
UA104885C2 (uk) Ізотіазолілоксифеніламідини та їх застосування як фунгіцидів
IN2012DN01233A (es)
SG178952A1 (en) Chemical compounds
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
PH12012501346A1 (en) Heteroaryl compounds and uses thereof
MX2011005934A (es) Compuestos organicos.
MX2012004780A (es) Inhibidores de akt.
IN2012DN00971A (es)
WO2011057262A3 (en) Treatment of infections with tp receptor antagonists
NZ602544A (en) Crystalline forms of a macrolide, and uses therefor
PH12015501609A1 (en) Phenicol antibacterials
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MX2012004078A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
MX2011008043A (es) Derivados de actagardina.
NZ596628A (en) Ketolide compounds having antimicrobial activity
MX2011006803A (es) Agentes antibacterianos novedosos para el tratamiento de infecciones gram positivas.
SG10201900541QA (en) Derivatives of xanthone compounds
IN2014DN03010A (es)
EP2611799A4 (en) PHARMACEUTICAL COMPOSITIONS OF LINEZOLID
MX2012004282A (es) Composiciones farmaceuticas.
MX2009009074A (es) Macrolidos basados en eritromicina.
PH12013501069A1 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: MEDICIS PHARMACEUTICAL CORPORATION

FG Grant or registration